| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
524.5140 | 275.1200 | 99.7900 | 35.2100 | 15.6420 |
| Cost of Revenue
|
0 | -- | 0 | 0 | 0 |
|
Gross Profit
|
75.1200 | -- | 99.7900 | 35.2100 | 15.6420 |
| Selling, General and Administrative Expenses
|
-8,809.2380 | -8,872.9150 | -19,242.5710 | -10,841.0240 | -1,026.5490 |
|
Research and Development Expenses
|
-176.8260 | -162.9730 | -1,127.7790 | -236.7100 | -136.4040 |
| Depreciation, Amortization and Depletion
|
-4,050.0410 | -3,865.3810 | -2,728.4110 | -637.9900 | -76.9280 |
| Other Income/Expense, Operating
|
0 | 0 | -13,475 | 0 | -- |
|
Operating Income/Expenses
|
-13,036.1050 | -12,901.2690 | -36,573.7610 | -11,715.7240 | -1,239.8810 |
|
Total Operating Profit/Loss
|
-12,511.5910 | -12,626.1490 | -36,473.9710 | -11,680.5140 | -1,224.2390 |
| Total Net Finance Income/Expense
|
-336.1090 | -410.4600 | -202.9450 | -40.9950 | -- |
| Net Investment Income
|
264.7000 | 197.2920 | 994.6870 | 0 | -- |
| Irregular Income/Expenses
|
321.3600 | 4,191.0740 | 1,946.3100 | 0 | 548.5630 |
|
Other Income/Expense, Non-Operating
|
-25.9610 | 22.8080 | 20.4900 | -9.7570 | -0.3620 |
|
Non-Operating Income/Expenses, Total
|
223.9900 | 4,000.7140 | 2,758.5420 | -50.7520 | 548.2010 |
|
Pretax Income
|
-12,287.6010 | -8,625.4350 | -33,715.4290 | -11,731.2660 | -676.0380 |
|
Provision for Income Tax
|
-56.9890 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-12,344.5900 | -8,625.4350 | -33,715.4290 | -11,731.2660 | -676.0380 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-12,344.5900 | -8,625.4350 | -33,715.4290 | -11,731.2660 | -676.0380 |
|
Net Income after Non-Controlling/Minority Interests
|
-12,344.5900 | -8,625.4350 | -33,715.4290 | -11,731.2660 | -676.0380 |
|
Net Income Available to Common Stockholders
|
-12,344.5900 | -8,625.4350 | -33,715.4290 | -11,731.2660 | -676.0380 |
|
Diluted Net Income Available to Common Stockholders
|
-12,344.5900 | -8,625.4350 | -33,715.4290 | -11,731.2660 | -676.0380 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-11,951.4920 | -8,214.9750 | -33,512.4840 | -11,690.2710 | -676.0380 |
|
EBITDA
|
-7,723.7720 | -4,171.9150 | -30,784.0730 | -11,052.2810 | -599.1100 |
|
Normalized EBITDA
|
-7,761.8420 | -7,737.8510 | -31,851.0170 | -6,173.6260 | -1,028.9230 |
|
Normalized Income
|
-12,374.6653 | -12,191.3710 | -34,782.3730 | -6,852.6110 | -1,105.8510 |
|
Total Unusual Items
|
-38.0700 | -3,565.9360 | -1,066.9440 | 4,878.6550 | -429.8130 |
|
Total Unusual Items Excluding Goodwill
|
-38.0700 | -3,565.9360 | -1,066.9440 | 4,878.6550 | -429.8130 |
|
Tax Effect of Unusual Items
|
-7.9947 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
12/31/2022 - 7/17/2026
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade